Key Lessons for Ethical and Affordable Access to GLP-1 Drugs Like Ozempic and Wegovy
How Other Nations’ Policies Can Guide Fair Access to Life-Saving Obesity and Diabetes Drugs Amid High Prices
Miles Meline, MBE
Miles Meline, MBE is a Senior Policy Coordinator at Penn LDI. He was also a Summer Undergraduate Mentored Research (SUMR) Scholar at LDI during the cohort of 2021. Prior to joining LDI, Miles completed research internships at CityStep.org and the Center of Interdisciplinary Research on Nicotine Addiction (CIRNA). He holds a BA in Philosophy and Biology from the University of Pennsylvania, a certificate in Medical Humanities from the University of Oxford, as well as a Master of Bioethics (MBE) from Harvard Medical School.
Related Content
Four Steps to Ethically Build Apps and Other Digital Health Tools
LDI Fellows Offer Specific Ways to Avoid Disparities and Serve Patients Better
How Low Trust in Government May Hurt Clinical Trial Participation
Evidence from Philadelphia During the Pandemic Suggests Ways To Build Trust
Chart of the Day: State Variation in Private Equity Ownership in Mental Health and Substance Use Disorder Facilities
New Geographic Trends Raise Questions About the Future of Behavioral Health Services
Nurses Faced More Challenges Providing Care in Black-Serving Hospitals During the Pandemic
The Challenges Created Disparities That Warrant Urgent Attention
Heart Patients Exercised More by Using Games and Incentives To Maintain Money, New Study Showed
Behavioral Interventions Can Boost Physical Activity and Promote Cardiovascular Health